New high-grade, near surface lithium-tantalum zone discovered ("Helios") at the CV13 Pegmatite: 8.8 m at 2.97%Li2O including ...

Rigel Pharmaceuticals recently issued full-year 2026 guidance, projecting total revenue of about US$275 million to US$290 million, including US$255 million to US$265 million in net product sales and ...

It has been seven years since my first Rigel Pharmaceuticals (RIGL) article, where I was bullish on TAVALISSE and the company's impressive pipeline. I was eyeing a potential buy early in 2019 as the ...

Don't miss 'The Curse of Rigel ' Expansion Launch Trailer for Wartales, an open-world turn-based strategy RPG developed by Shiro Games. Players will enforce the King's will to venture into the County ...

Rigel Pharma is a profitable biotech with three FDA-approved drugs, experiencing accelerating revenue growth led by Tavalisse's strong performance. RIGL trades at a significant discount to biotech ...

Fintel reports that on November 5, 2025, Jefferies upgraded their outlook for Rigel Pharmaceuticals (NasdaqGS:RIGL) from Hold to Buy. Analyst Price Forecast Suggests 3.30% Upside As of October 30, ...

Rigel Pharmaceuticals (RIGL) could be a solid choice for investors given the company's remarkably improving earnings outlook. While the stock has been a strong performer lately, this trend might ...

Eli Lilly has pulled out of the central nervous system (CNS)-focused portion of a $960 million biobucks deal centered on Rigel Pharmaceuticals’ receptor-interacting serine/threonine-protein kinase 1 ...

SOUTH SAN FRANCISCO, Calif. (AP) — SOUTH SAN FRANCISCO, Calif. (AP) — Rigel Pharmaceuticals Inc. (RIGL) on Tuesday reported net income of $27.9 million in its third quarter. On a per-share basis, the ...